Compounds > phosphorylcholine

phosphorylcholine and dactolisib

phosphorylcholine has been researched along with dactolisib in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatt, AP; Bhende, PM; Damania, B; Dittmer, DP; Roy, D; Sin, SH1
Civallero, M; Cosenza, M; Marcheselli, L; Pozzi, S; Sacchi, S1
Bathen, TF; Engebråten, O; Esmaeili, M; Gribbestad, IS; Moestue, SA; Mælandsmo, GM1
Boratyn, E; Durbas, M; Horwacik, I; Kamycka, E; Rokita, H1
Cartagena-Rivera, AX; Chadwick, RS; Logue, JS1

Other Studies

5 other study(ies) available for phosphorylcholine and dactolisib

ArticleYear
Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.
    Blood, 2010, Jun-03, Volume: 115, Issue:22

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autocrine Communication; Cell Line, Tumor; Cell Proliferation; Cytokines; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Lymphoma, Primary Effusion; Mice; Mice, Inbred NOD; Mice, SCID; Paracrine Communication; Phosphoinositide-3 Kinase Inhibitors; Phosphorylcholine; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Quinolines; Rosiglitazone; Thiazolidinediones; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2010
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy.
    Expert opinion on investigational drugs, 2012, Volume: 21, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bone Marrow; Cell Line, Tumor; Cell Proliferation; Everolimus; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Indoles; Lymphoma, Mantle-Cell; Phosphorylation; Phosphorylcholine; Protein Kinases; Quinolines; Sirolimus

2012
Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
    Magnetic resonance in medicine, 2014, Volume: 71, Issue:6

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Ethanolamines; Female; Humans; Imidazoles; Magnetic Resonance Spectroscopy; Mice; Phosphatidylethanolamines; Phosphorus Isotopes; Phosphorylcholine; Quinolines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2014
GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines.
    International journal of oncology, 2015, Volume: 47, Issue:3

    Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Drug Synergism; Gangliosides; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neuroblastoma; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quinolines; Quinoxalines; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases

2015
c-Src activity is differentially required by cancer cell motility modes.
    Oncogene, 2018, Volume: 37, Issue:16

    Topics: Actins; Amino Acid Substitution; Butadienes; Cell Adhesion; Cell Movement; Dasatinib; Humans; Imidazoles; Mutant Proteins; Neoplasms; Nitriles; Phosphorylcholine; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Quinolines; Tumor Cells, Cultured

2018